Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk
Publication
, Conference
Masha, N; Sutton, P; Hartsell, F; Skeen, M; Walker, B; Hudak, N; Eckstein, C; Shah, S
Published in: MULTIPLE SCLEROSIS JOURNAL
2022
Duke Scholars
Published In
MULTIPLE SCLEROSIS JOURNAL
EISSN
1477-0970
ISSN
1352-4585
Publication Date
2022
Volume
28
Issue
1_SUPPL
Start / End Page
79 / 79
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Masha, N., Sutton, P., Hartsell, F., Skeen, M., Walker, B., Hudak, N., … Shah, S. (2022). Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk. In MULTIPLE SCLEROSIS JOURNAL (Vol. 28, pp. 79–79).
Masha, N., P. Sutton, F. Hartsell, M. Skeen, B. Walker, N. Hudak, C. Eckstein, and S. Shah. “Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk.” In MULTIPLE SCLEROSIS JOURNAL, 28:79–79, 2022.
Masha N, Sutton P, Hartsell F, Skeen M, Walker B, Hudak N, et al. Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk. In: MULTIPLE SCLEROSIS JOURNAL. 2022. p. 79–79.
Masha, N., et al. “Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk.” MULTIPLE SCLEROSIS JOURNAL, vol. 28, no. 1_SUPPL, 2022, pp. 79–79.
Masha N, Sutton P, Hartsell F, Skeen M, Walker B, Hudak N, Eckstein C, Shah S. Effect of B-cell Depleting MS Therapies on SARS-CoV-2 Risk. MULTIPLE SCLEROSIS JOURNAL. 2022. p. 79–79.
Published In
MULTIPLE SCLEROSIS JOURNAL
EISSN
1477-0970
ISSN
1352-4585
Publication Date
2022
Volume
28
Issue
1_SUPPL
Start / End Page
79 / 79
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences